A new Oura ring is coming — and the CEO believes it will make doctors take the trendy wearable seriously

• New partnerships allow the ring to automatically alert insurers like Essence Health when detecting conditions such as sleep apnea, triggering AI-driven diagnostic follow-ups and treatment pathways without human intervention
• Oura has achieved $11 billion valuation and sold 5.5 million rings with $1 billion revenue in 2025, maintaining 80% customer retention after one year on its $5.99 monthly subscription (better than Netflix or Spotify)
• The device launches June 4 at $399 base price, entering a $95 billion global wearables market amid a US physician shortage, with additional fees for AI clinical consultations and doctor access through Counsel Health

Oura Ring Launches AI-Powered Upgrade Ahead of Planned IPO

Key Developments:

Oura is releasing a new smart ring featuring integrated AI health advisors, marking a significant push into clinical healthcare. The device, starting at $399 with pre-orders beginning now and shipping June 4, is 40% smaller than its predecessor and includes advanced health monitoring capabilities.

Financial Highlights:

• Company valuation: $11 billion (up from $800 million in 2022)
• 2025 revenue: $1 billion (doubled year-over-year)
• Units sold: 5.5 million rings to date
• Filed for confidential IPO last week
• Subscription model: $5.99/month with 80% retention rate after one year

Strategic Partnerships:

Oura partnered with Essence Health (Medicare Advantage insurer) to automatically detect conditions like sleep apnea and trigger AI-driven diagnostic workflows. A second partnership with Counsel Health enables users to escalate health concerns from AI chatbots to board-certified physicians for an additional fee beyond the base subscription.

Technical Capabilities:

The new ring detects blood pressure signals, breathing disturbances, and other health metrics. Software additions include a GLP-1 Companion for monitoring responses to weight-loss drugs and enhanced symptom detection.

Market Context:

The global wearables market has reached $95 billion with 1.1 billion devices in use, while the US faces a growing physician shortage. CEO Tom Hale, who joined in 2022, positions the upgrade as transformative healthcare technology that enables automated treatment pathways from detection to clinical intervention.

The subscription-based revenue model provides ongoing cash flow beyond hardware sales, with engagement metrics showing users check the app three times daily.